Navigation Links
BioMed Realty Trust Announces Tax Treatment of 2007 Distributions
Date:1/29/2008


SAN DIEGO, Jan. 29 /PRNewswire-FirstCall/ -- BioMed Realty Trust, Inc. (NYSE: BMR) today announced the tax treatment of its 2007 distributions as follows:

Security Description: Common Stock

CUSIP: 09063H107

Ticker Symbol: BMR

Total Allocable

Record Payable Distribution to Taxable Ordinary

Date Date Per Share 2007 Dividend

12/29/2006 1/16/2007 $0.290000 $0.290000 $0.237498

3/30/2007 4/16/2007 $0.310000 $0.310000 $0.253877

6/29/2007 7/16/2007 $0.310000 $0.310000 $0.237089

9/28/2007 10/15/2007 $0.310000 $0.310000 $0.253877

Totals $1.220000 $1.220000 $0.982341

Unrecaptured

Record Payable Return of Long-Term Section 1250

Date Date Capital Capital Gain Gain

12/29/2006 1/16/2007 $0.052502 $0.000000 $0.000000

3/30/2007 4/16/2007 $0.056123 $0.000000 $0.000000

6/29/2007 7/16/2007 $0.056123 $0.016788 $0.009224

9/28/2007 10/15/2007 $0.056123 $0.000000 $0.000000

Totals $0.220871 $0.016788 $0.009224
Security Description: 7.375% Series A Cumulative Redeemable Preferred Stock
CUSIP: 09063H206

Ticker Symbol: BMR PR A

Total Taxable

Record Payable Distribution Allocable Ordinary

Date Date Per Share to 2007 Dividend

3/30/2007 4/16/2007 $0.455820 $0.455820 $0.455820

6/29/2007 7/16/2007 $0.455820 $0.455820 $0.432753

9/28/2007 10/15/2007 $0.460940 $0.460940 $0.460940

Totals $1.372580 $1.372580 $1.349513

Unrecaptured

Record Payable Return of Long-Term Section 1250

Date Date Capital Capital Gain Gain

3/30/2007 4/16/2007 $0.000000 $0.000000 $0.000000

6/29/2007 7/16/2007 $0.000000 $0.023067 $0.012674

9/28/2007 10/15/2007 $0.000000 $0.000000 $0.000000

Totals $0.000000 $0.023067 $0.012674

The distributions payable on January 15, 2008 to shareholders of record on December 31, 2007 are considered 2008 distributions for federal income tax purposes.

The company did not incur any foreign taxes during 2007. In addition, only for purposes of calculating alternative minimum taxable income under Section 55 of the Internal Revenue Code of 1986, as amended, the company apportions $0.002 per common share and Series A preferred share attributable to depreciation, each assuming a full year of ownership. Stockholders are encouraged to consult with their personal tax advisors as to their specific tax treatment of BioMed Realty Trust distributions.

About BioMed Realty Trust

BioMed Realty Trust, Inc. is a real estate investment trust (REIT) focused on Providing Real Estate to the Life Science Industry(R). The company's tenants primarily include biotechnology and pharmaceutical companies, scientific research institutions, government agencies and other entities involved in the life science industry. BioMed Realty Trust owns or has interests in 68 properties, representing 104 buildings with approximately 8.5 million rentable square feet, as well as approximately 1.9 million square feet of development in progress. These properties are located predominantly in the major U.S. life science markets of Boston, San Diego, San Francisco, Seattle, Maryland, Pennsylvania and New York/New Jersey, which have well-established reputations as centers for scientific research. Additional information is available at http://www.biomedrealty.com.

CONTACT: Kent Griffin

Chief Financial Officer

(858) 485-9840


'/>"/>
SOURCE BioMed Realty Trust, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Serica Technologies Expands Facilities in Massachusetts, Combines State-Of-The-Art Textile Engineering and Biomedical Manufacturing
2. BioMed Realty Trust Declares Third Quarter 2007 Common Stock and Preferred Stock Dividends
3. CryoLife Signs Distribution Agreement for Inclusion of BioGlue(R) Surgical Adhesive in Hernia Repair Kit with Proxy Biomedical Surgical Meshes
4. Verax Biomedical Receives 510 (k) Clearance from FDA for Platelet PGD Test
5. SLIM Search, Inc. Sponsors Next Generation Sequencing Conference for the Biomedical Market
6. NCIIA Announces Launch of 4th Annual Student Biomedical Innovation Competition
7. New Scientists Boost Disease-based Research at Boston Biomedical Research Institute
8. Foundation for Biomedical Research Board Chairman Awarded Congressional Gold Medal
9. Crux Biomedical Announces First Successful U.S. Implant of Its New Retrievable Inferior Vena Cava (IVC) Filter
10. Environmental Tectonics Corporations BioMedical Division Announces New Contract
11. Avery Biomedical Devices, Inc. Appoints Elefteriades to its Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... ... February 09, 2016 , ... Clinovo , the cloud-based ... Electronic Data Capture (EDC) system ClinCaptureand its new Contract Research Organization (CRO) Partner ... Conference in San Mateo, California on February 10th and 11th. Watch 2-min ...
(Date:2/9/2016)... ... February 09, 2016 , ... PharmApprove ... for the National Organization for Rare Disorders (NORD). Dorman will lead PharmApprove efforts ... are heard throughout the drug regulatory review process. , “Adding Diane Dorman is ...
(Date:2/9/2016)... February 9, 2016 Three-Year Initiative Supports ... to Take Part in Life-Changing Camp ... designed to positively affect the lives of children born with rare ... --> SHPG ) is announcing a new initiative designed to ... well as the future of rare disease care. --> ...
(Date:2/8/2016)... Pa. , Feb. 8, 2016 Should ... standard bone cement products to prevent infection after standard ... that the experts at ECRI Institute have been fielding ... Infection or Fighting Your Bottom Line?" ... Your Bottom Line?" --> While ...
Breaking Biology Technology:
(Date:2/2/2016)... 2016 Checkpoint Inhibitors for Cancer – ... Are you interested in the future of cancer ... inhibitors. Visiongain,s report gives those predictions to 2026 ... level. Avoid falling behind in data or ... revenues those emerging cancer therapies can achieve. There ...
(Date:2/2/2016)... RESTON, Va. , Feb. 2, 2016 /PRNewswire/ ... contract award from the U.S. Army Research Office ... extend the range and sensitivity of the company,s ... DoD,s Past Accounting Mission and, more generally, defense-related ... its DNA phenotyping capabilities (predicting appearance and ancestry ...
(Date:2/1/2016)... 2016 Rising sales of consumer ... touchfree intuitive gesture control market size ... of consumer electronics coupled with new technological advancements to ... size through 2020   --> ... technological advancements to drive global touchfree intuitive gesture control ...
Breaking Biology News(10 mins):